APP Users: If unable to download, please re-install our APP.
Only logged in User can create notes
Only logged in User can create notes

General Studies 3 >> Science & Technology

audio may take few seconds to load

HPV VACCINE

HPV VACCINE

 

Context

 
India will have an indigenously developed human Papillomavirus (HPV) vaccine, Cervavac from the Serum Institute of India (SII).
It will offer protection against cervical cancer, the second largest killer among cancers in women.
With a cheaper, indigenously developed vaccine against HPV soon to be available, routine immunisation of all girls would be extremely cost-effective.
 
 

How does vaccination against an infection protect against cancer?

 
  • Cervical cancer continues to be one of the only vaccine-preventable cancers.
  • Almost all cervical cancers are found in women who have a history of HPV infection.
  • Over 80 per cent of women have an HPV infection in their lifetime and almost all of them can clear it.
  • But in some people, some high-risk types of HPV persist and lead to cervical cancer.
 
In addition, having multiple sexual partners, poor hygiene and smoking are other factors that increase the risk of developing cervical cancer.
 
 
  • The best way to prevent cancer is to prevent an infection in the first place and that is what HPV vaccines do.
  • There are two to four types of HPV that lead to almost 70 to 80 per cent of all cervical cancers and vaccines prevent these infections.
  • Since the virus is sexually transmitted, it has to be given to teenage girls before they are sexually active.
  • Once an infection happens, the vaccine cannot clear it out. Hence, the effectiveness of the vaccine keeps dropping with age.
 
 

How will the new vaccine help?

 
At present, there are two, HPV vaccines available- Glaxosmithline's Cervarix and Merck's Gardasil.
 
The first one protects against the two most common types, HPV 16 and HPV 18, whereas the second one protects against two additional types, HPV 6 and HPV 11.
 
Now, these vaccines cost between 2500 and 3500 rupees per dose, with teenagers requiring at least two doses and those getting it later in life needing three.
 
 
  • The problem then is that universal immunisation of all teenage girls becomes an expensive proposition.
  • The Delhi government 2016 decided to start immunising schoolgirls at the Delhi State Cancer Institute (DSCI).
 
The programme was halted for two years during the pandemic, mainly because of two reasons.
  1. Not many people were coming to the hospital to get a shot.
  2. We were unsure what the immune response would be like in children who might have a current infection or one recently.
 
  • Now, Cervarix is not readily available in India, so we had to start using the other one, which is costlier.
  • started the tendering process for a fresh batch of vaccines, and we realised that the India-made vaccine will soon be available.
  • This is the role the new vaccine will play.
  • It will make it cheaper and more cost-effective for governments to give the shot under public health programmes.
  • It will become a part of the national programme as well.
 

 Impact of a universal vaccination programme

 
  • The impact will be tremendous if we can vaccinate 90 per cent of teenage girls.
  • It will drastically bring down the incidence and deaths caused by cervical cancer in India, which is more important because the country contributes to about a fourth of the global mortality from Cervical cancer.
  • India sees about 1.2 lakh cervical cancer cases a year and around 67, 000 deaths a year.
  • Even without vaccination, incidence and deaths due to cervical cancers are declining in India and globally.
  • It has moved down to the second position, after breast cancer, from being the biggest killer among cancers in women in India.
  • The vaccine wipes out more than two-thirds of the cases and deaths that are caused by the four most common types of HPV.
 

Effects of vaccination

 
  • There are previous discussions the government had about including it as a part of the National immunisation effort.
  • It did not happen because of unfortunate incidents in Andhra Pradesh and Gujarat.
  • There were procedural lapses in the trial there, which led to the government going on the back foot. Globally HPV vaccine is very safe and effective.
  • There is a minuscule chance that a person has an adverse effect, which is true of any vaccine.
 
 

Who needs to get the vaccine?

 
  • The vaccine can only prevent infections so it needs to be given to girl children starting at the age of 11 or 12 years, up to 16 years.
  • Even after that, the vaccine can be given.
 
If the person has already been exposed to one type of HPV, then they will be protected against the other types that the vaccine works against.
 
 
 

For those who have crossed that age, how can cervical cancer be prevented? 

 
  • For those who are past the age of HPV vaccination, regular screening is the best way to keep an eye out for whether they have cervical cancer.
  • Earlier, we used to do a pap smear (a procedure where a small brush is used to remove cells from the cervix to be studied under the microscope). we now perform HIV tests.
  • The sample is collected similarly but it looks for the high-risk types of HPV in the cells.
  • This test should be done starting two to three years after sexual activity begins, then every five years until the age of 65.
 
The government has already prepared a module for screening the cervix along with the oral cavity and breast at health and wellness centres so that cancers can be detected at the earliest.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Share to Social